| Both decision |
91.1 |
276 |
| Self-decision |
0.7 |
2 |
| Supervisor decision |
8.3 |
25 |
|
Preferred material for pulpal lining
|
| Biodentine (Septodont, France) |
2.3 |
7 |
|
Calcium hydroxide Ca(OH)
2
|
61.4 |
186 |
| Flowable resin composite |
0.3 |
1 |
| Glass ionomer cement (GIC) |
26.7 |
81 |
| Mineral trioxide aggregate (MTA) |
5.9 |
18 |
| Resin modified glass ionomer cement (RMGIC) |
1.3 |
4 |
| TeraCal (resin modified calcium silicate) (BISCO, United States) |
0.3 |
1 |
| Zinc oxide eugenol (ZnOE) |
1.7 |
5 |
|
Preferred material for pulpotomy
|
| Biodentine (Septodont, France) |
5.6 |
17 |
|
Ca(OH)
2
|
44.2 |
134 |
| Ferric sulfate |
30.7 |
93 |
| Formocresol |
5.6 |
17 |
| MTA |
13.5 |
41 |
| ZnOE |
0.3 |
1 |
|
Reasons for choosing particular treatment material for treatment intervention
|
| Ease of use, familiarity with the technique |
70.6 |
214 |
| Good clinical result |
74.9 |
156 |
| Recommended by supervisor/colleagues |
61.7 |
147 |
| Recommended by clinical research |
44.8 |
98 |
| Recommended in textbook |
35.9 |
80 |
| Cost-effectiveness |
38.3 |
96 |
|
Factors that affect the treatment choice
|
| Patient's general health |
51.5 |
158 |
| Patient's age |
76.0 |
278 |
| Patient's oral health |
71.1 |
217 |
| Patient's attitude and preference |
70.5 |
216 |
| Type of tooth (anterior, premolar, molar) |
74.6 |
228 |
| Stage of root development (incomplete/complete) |
76.4 |
234 |
| Further restoration needs of tooth |
60.9 |
184 |
| Duration of the total treatment |
42.5 |
131 |
